| EMA number | EMEA/H/C/000197 |
| ATC code | H05BA01 |
| Authorisation | 11 January 1999 |
| Withdrawn | 29 October 2008 |
| Revision | - |
Calcitonin is indicated for: Prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures Paget's disease Hypercalcaemia of malignancy